📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Pharmacyclics

1.1 - Company Overview

Pharmacyclics Logo

Pharmacyclics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of clinical-stage biopharmaceutical research and development focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Pharmacyclics

Affini-T Therapeutics Logo

Affini-T Therapeutics

HQ: United States Website
  • Description: Provider of autologous TCR-T cell therapies targeting oncogenic driver mutations in solid tumors and off-the-shelf bispecific T cell engagers. Offers the TAILOR discovery platform leveraging machine learning and high-throughput screening, TUNE to enhance persistence and functionality via synthetic biology, and THRIVE for optimized manufacturing and gene editing. Conducts clinical trials.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Affini-T Therapeutics company profile →
AVEO Oncology Logo

AVEO Oncology

HQ: United States Website
  • Description: Provider of targeted cancer therapeutics and oncology development platforms. Products include FOTIVDA (tivozanib), an oral VEGFR TKI approved for relapsed/refractory advanced RCC. Pipeline includes ficlatuzumab (anti-HGF) for HNSCC, AV-380 (anti-GDF15) for cancer cachexia, and AV-203, a HER3 inhibitory antibody. Offers an integrated cancer biology and Human Response platform for efficient discovery and development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full AVEO Oncology company profile →
GeminX Pharmaceuticals Logo

GeminX Pharmaceuticals

HQ: Canada Website
  • Description: Provider of novel, targeted cancer therapeutics, dedicated to the discovery, development and commercialization of treatments based on research on the Bcl-2 cell death regulation pathway, including the discovery of GX15-070 (obatoclax), a novel small molecule.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full GeminX Pharmaceuticals company profile →
Myriad Genetics Logo

Myriad Genetics

HQ: United States Website
  • Description: Provider of genetic testing and molecular profiling solutions, including hereditary cancer risk assessment (MyRisk), pharmacogenomic testing for mental health medications (GeneSight), prostate cancer aggressiveness evaluation (Prolaris), tumor genomic profiling (Precise), carrier screening (Foresight), and non-invasive prenatal screening (Prequel).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Myriad Genetics company profile →
Nativis Logo

Nativis

HQ: United States Website
  • Description: Provider of therapeutic modalities in development for the treatment of serious disease.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Nativis company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Pharmacyclics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Pharmacyclics

2.2 - Growth funds investing in similar companies to Pharmacyclics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Pharmacyclics

4.2 - Public trading comparable groups for Pharmacyclics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Pharmacyclics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Pharmacyclics

What does Pharmacyclics do?

Pharmacyclics is a provider of clinical-stage biopharmaceutical research and development focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases.

Who are Pharmacyclics's competitors?

Pharmacyclics's competitors and similar companies include Affini-T Therapeutics, AVEO Oncology, GeminX Pharmaceuticals, Myriad Genetics, and Nativis.

Where is Pharmacyclics headquartered?

Pharmacyclics is headquartered in United States.

How many employees does Pharmacyclics have?

Pharmacyclics has 1,000 employees 🔒.

When was Pharmacyclics founded?

Pharmacyclics was founded in 2010 🔒.

What sector and industry vertical is Pharmacyclics in?

Pharmacyclics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Pharmacyclics

Who are the top strategic acquirers in Pharmacyclics's sector and industry

Top strategic M&A buyers and acquirers in Pharmacyclics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Pharmacyclics?

Top strategic M&A buyers groups and sectors for Pharmacyclics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Pharmacyclics's sector and industry vertical

Which are the top PE firms investing in Pharmacyclics's sector and industry vertical?

Top PE firms investing in Pharmacyclics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Pharmacyclics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Pharmacyclics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Pharmacyclics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Pharmacyclics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Pharmacyclics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Pharmacyclics?

The key public trading comparables and valuation benchmarks for Pharmacyclics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Pharmacyclics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Pharmacyclics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Pharmacyclics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Pharmacyclics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Pharmacyclics's' sector and industry vertical?

Access recent funding rounds and capital raises in Pharmacyclics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Pharmacyclics